Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 161–161 | Cite as

Ipilimumab/nivolumab

Paraneoplastic hyperleucocytosis: case report
Case report
  • 9 Downloads

Reference

  1. Gambichler T, et al. Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy. Journal for ImmunoTherapy of Cancer 6: 113, No. 1, 30 Oct 2018. Available from: URL: http://doi.org/10.1186/s40425-018-0430-y - Germany

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations